Loomis, Sayles & Company’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-357
Closed -$28.9K 754
2026
Q1
$28.9K Hold
357
﹤0.01% 651
2025
Q4
$27.3K Buy
357
+88
+33% +$6.75K ﹤0.01% 662
2025
Q3
$21.4K Sell
269
-89
-25% -$6.66K ﹤0.01% 689
2025
Q2
$25.1K Sell
358
-53
-13% -$3.88K ﹤0.01% 688
2025
Q1
$30K Sell
411
-228
-36% -$16.1K ﹤0.01% 684
2024
Q4
$44K Buy
639
+189
+42% +$14.4K ﹤0.01% 679
2024
Q3
$38K Buy
+450
New +$34.7K ﹤0.01% 656
2020
Q4
Sell
-11
Closed -$1K 819
2020
Q3
$1K Hold
11
﹤0.01% 644
2020
Q2
$1K Hold
11
﹤0.01% 683
2020
Q1
$1K Buy
+11
New +$835 ﹤0.01% 716

Other funds holding NHI

Loomis, Sayles & Company's NHI Position: Q2 2026 in Review

Loomis, Sayles & Company sold out of National Health Investors (NHI) in Q2 2026, closing a stake of 357 shares — an estimated $28.9K sold.

Loomis, Sayles & Company first reported a position in NHI in Q1 2020 and held it in 10 quarters. The position peaked at $44K in Q4 2024. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Loomis, Sayles & Company reported no remaining National Health Investors position as of Q2 2026 after selling out during the quarter.
  • Loomis, Sayles & Company sold 357 National Health Investors shares in Q2 2026, an estimated $28.9K.
  • Loomis, Sayles & Company first reported a position in National Health Investors in Q1 2020 and held it in 10 quarters.
  • Loomis, Sayles & Company's National Health Investors position peaked at $44K in Q4 2024.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.